Emergent BioSolutions (EBS) Share-based Compensation (2010 - 2026)
Emergent BioSolutions (EBS) posted Share-based Compensation of $4.2 million for Q3 2026, down 12.5% from $4.8 million a year earlier and down 39.1% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Share-based Compensation (2010 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Share-based Compensation at Emergent BioSolutions was $18.3 million, up 20.4% year-over-year; for FY2025, it was $16.2 million, down 10.0% from FY2024.
- Annual Share-based Compensation has declined for three consecutive years, with a five-year compound annual growth rate of -20.7% (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Share-based Compensation was $18 million in FY2024 (-22.1%), $23.1 million in FY2023 (-48.8%), $45.1 million in FY2022 (+6.4%) and $42.4 million in FY2021 (-18.1%).
- Quarterly Share-based Compensation has run from a low of $1.5 million in Q1 2025 to a high of $12.3 million in Q2 2022 over five years.
- On a year-over-year basis, Share-based Compensation increased in five of the last eight quarters, with growth averaging 14.1%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2025, with growth of 108.7%; the weakest was Q1 2025, with a decline of 74.6%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $6.9 million (Q2 2026), $1.9 million (Q1 2026) and $5.3 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | 4.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.20 Mn |
| Jun 30, 2026 | 6.90 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Dec 31, 2025 | 5.30 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 4.60 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 5.50 Mn |
| Mar 31, 2024 | 5.90 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 8.30 Mn |
| Mar 31, 2023 | 6.80 Mn |
| Dec 31, 2022 | 11.70 Mn |
| Sep 30, 2022 | 11.20 Mn |
| Jun 30, 2022 | 12.30 Mn |
| Mar 31, 2022 | 9.90 Mn |
| Dec 31, 2021 | 10.10 Mn |
API Access
Emergent BioSolutions Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();